Product Information

KETOCONAZOLE 2% FOAM is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $5.6210 per GM under NDC 45802053232. Its NADAC has been published 169 times since Nov 28, 2013.

FDA first approved this application on Aug 25, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the ketoconazole market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

KETOCONAZOLE 2% FOAM

ketoconazole
$5.6210per GM
High Outlier

Strength

2 g/100g

NDC

45802053232

Classification

Generic

Dosage Form

AEROSOL, FOAM

Route

TOPICAL

Effective Date

10/21/2026

Active Ingredients

KETOCONAZOLE

Approval Type

Generic (ANDA)

FDA Application

ANDA091550

FDA Approved

8/25/2011

TE Code

AB

On Market Since

8/30/2011

Pharmacological Classes

Azole Antifungal
Azoles
Cytochrome P450 3A4 Inhibitors
Cytochrome P450 3A5 Inhibitors
P-Glycoprotein Inhibitors

Price Statistics

The NADAC for KETOCONAZOLE 2% FOAM has been published 169 times since Nov 28, 2013, and over the history we have for it it has risen 62.3%. The table below summarizes its recorded NADAC range and movement.

Current price$5.6210 per GM
All-time high$8.0876 (Dec 11, 2024)
All-time low$3.4637 (Nov 28, 2013)
52-week high$6.3867
52-week low$5.2798
Median price$5.9979
Average price$5.7823
Largest weekly change+92.7% (Apr 17, 2024)
Weeks tracked169
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

+0.4%

3M

-1.2%

6M

-6.3%

1Y

+2.8%

3Y

+62.3%

5Y

+62.3%

All

+62.3%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 37% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 37%

1 alternative • Same active ingredient

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of KETOCONAZOLE 2% FOAM?

The current National Average Drug Acquisition Cost (NADAC) for KETOCONAZOLE 2% FOAM, manufactured by Padagis Israel Pharmaceuticals Ltd, is $5.6210 per GM (NDC 45802053232), effective Nov 11, 2026.

How has the price of KETOCONAZOLE 2% FOAM changed over time?

Over the history we have for it, the NADAC for KETOCONAZOLE 2% FOAM has risen 62.3%. It has been tracked across 169 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for KETOCONAZOLE 2% FOAM?

Since Nov 28, 2013, the NADAC for KETOCONAZOLE 2% FOAM has ranged from a low of $3.4637 (Nov 28, 2013) to a high of $8.0876 (Dec 11, 2024), with a median of $5.9979 per GM.

Are there cheaper alternatives to KETOCONAZOLE 2% FOAM?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, KETOCONAZOLE 2% FOAM, is $3.5544 per GM — about 37% below KETOCONAZOLE 2% FOAM.

Who manufactures KETOCONAZOLE 2% FOAM?

KETOCONAZOLE 2% FOAM (NDC 45802053232) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.